SR

Shriram Ramesh Ambekar

Active Director Director DIN 09764293
DIN 09764293 First appointment Oct 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value •••• Premium profile

About Shriram Ramesh Ambekar

Data last updated:

Shriram Ramesh Ambekar is a Director at Bilmeds Pharmaceuticals (Opc) Private Limited (since 2022). The company operates in Chemicals. Bilmeds Pharmaceuticals (Opc) Private Limited reported revenue of ₹38.8 Lakh (FY 2024).

DIN 09764293
Primary Designation Director
Industry Chemicals
First Appointment 13 Oct 2022
Oldest Company Age 4 yrs
Largest company Bilmeds Pharmaceuticals (Opc) Private Limited · ₹38.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Oct 20222022₹38.8 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Bilmeds Pharmaceuticals (Opc) Private Limited
Premium access

Shareholding and investment profile for Shriram Ramesh Ambekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shriram Ramesh Ambekar

Shriram Ramesh Ambekar currently holds 1 directorship: Bilmeds Pharmaceuticals (Opc) Private Limited (Director, since 13 Oct 2022, revenue ₹38.8 Lakh (FY 2024)).

Shriram Ramesh Ambekar was first appointed on 13 Oct 2022 as Director at Bilmeds Pharmaceuticals (Opc) Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available